FindTrial
Sign In

Safety and feasibility study of Cognitive Behavioral Therapy for Obsessive Compulsive Disorder – an open-label pilot study

Safety and feasibility study of Cognitive Behavioral Therapy for Obsessive Compulsive Disorder – an open-label pilot study - Cognitive Behavioral Therapy for Obsessive Compulsive Disorder-an open-label pilot study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008403
Enrollment
30
Registered
2012-07-17
Start date
2012-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder

Interventions

Cognitive Behavioral Therapy for Obsessive Compulsive Disorder

Sponsors

Cognitive Behavioral Therapy Center OCD Study Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects with current DSM-IV Obsessive Compulsive Disorder at screening. 2. Aged 20 years or order, and 65 years or younger at screening. 3. Subjects who give full consent in the participation of the study.

Exclusion criteria

Exclusion criteria: 1. No alcohol or substance use disorder in 6 months prior to the screening. 2. No other primary DSM-IV Axis I Disorders except Obsessive Compulsive Disorder in 6 months prior to the screening. 3. No comorbid of antisocial personality disorder. 4. No serious suicidal ideation at screening. 5. Evidence of unable to participate half or more of the intervention phase. 6. No past treatment of CBT for Obsessive Compulsive Disorder. 7. No major cognitive deficits for CBT treatment at screening. 8. No severe or unstable medical co-morbidities at screening. 9. Other relevant reason decided by the investigators.

Design outcomes

Primary

MeasureTime frame
Y-BOCS (Yale-Brown Obsessive Compulsive Scale)—

Secondary

MeasureTime frame
BDI-II(Beck Depression Inventory) SF-36(Quality of Life Scale) OASIS(Overall Anxiety Severity and Impairment Scale) EQ5D(Quality of Life Scale) QIDS-J(Quick Inventory of Depressive Symptomatology) GRID-HAMD(GRID-Hamilton Depression Rating Scale) MRI—

Countries

Japan

Contacts

Public ContactMasaru Horikoshi, Ph.D.

National Center of Neurology and Psychiatry Cognitive Behavioral Therapy Center

mhorikoshi@ncnp.go.jp042-341-2712

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026